Lexicon Pharmaceuticals
LXRX
#7142
Rank
S$0.65 B
Marketcap
S$1.81
Share price
-1.41%
Change (1 day)
108.52%
Change (1 year)

Revenue for Lexicon Pharmaceuticals (LXRX)

Revenue in 2025 (TTM): S$92.76 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is S$91.83 Million. In 2024 the company made a revenue of S$42.24 Million an increase over the revenue in the year 2023 that were of S$1.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lexicon Pharmaceuticals from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) S$92.76 M119.58%
2024 S$42.24 M2554.66%
2023 S$1.59 M754.04%
2022 S$0.18 M-53.75%
2021 S$0.4 M-98.73%
2020 S$31.74 M-92.69%
2019 S$0.43 B400.29%
2018 S$86.79 M-28.17%
2017 S$0.12 B0.17%
2016 S$0.12 B-34.42%
2015 S$0.18 B509.01%
2014 S$30.19 M972.66%
2013 S$2.81 M111.4%
2012 S$1.33 M-44.38%
2011 S$2.39 M-62.12%
2010 S$6.32 M-57.91%
2009 S$15.02 M-67.5%
2008 S$46.22 M-35.91%
2007 S$72.11 M-35.39%
2006 S$0.11 B-11.41%
2005 S$0.12 B25.1%
2004 S$0.10 B38.39%
2003 S$72.78 M19.16%
2002 S$61.07 M-89.2%
2001 S$0.56 B2157.42%
2000 S$25.05 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eterna Therapeutics
ERNA
S$0 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$18.46 B 20,005.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S$0.81 B 789.87%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$4.00 B 4,266.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$56.67 B 61,616.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.39 B 328.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$5.55 B 5,951.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.32 B 254.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S$0.27 B 201.90%๐Ÿ‡บ๐Ÿ‡ธ USA